Image

The Multi-Omics Analysis of Lens Zonule Relaxation in The PACG Pathogenesis

The Multi-Omics Analysis of Lens Zonule Relaxation in The PACG Pathogenesis

Recruiting
50 years and older
All
Phase N/A

Powered by AI

Overview

Compared with primary angle-closure glaucoma (PACG) patients without zonular laxity and the control group, there are differentially expressed molecules in PACG patients with zonular laxity, and a potential mechanistic network can be constructed therefrom.

Description

This study investigates the pathogenesis of PACG by conducting multi-omics analyses of aqueous humor, blood and anterior lens capsule samples from PACG patients with and without concomitant zonular abnormalities, aiming to elucidate the etiology of zonular abnormalities and uncover novel mechanisms underlying their involvement in the pathogenesis of glaucoma.

Eligibility

Inclusion Criteria:

  • Clinically diagnosed with primary angle-closure glaucoma (PACG)
  • Aged ≥ 50 years, no gender restriction
  • Case Group A: Undergoing glaucoma surgery with intraoperatively confirmed significant zonular laxity
  • Case Group B: Undergoing glaucoma surgery with intraoperatively confirmed normal zonular morphology
  • Control group: age- and sex-matched with case groups; clinically diagnosed with age-related cataract; normal anterior chamber depth and angle; no history or signs of glaucoma; undergoing cataract surgery

Exclusion Criteria:

  • Secondary glaucoma
  • History of previous intraocular surgery
  • Systemic diseases that can cause abnormal ocular zonules
  • Other severe ocular diseases
  • Long-term use of medications affecting connective tissue metabolism

Study details
    Primary Angle-Closure Glaucoma

NCT07539675

Zhongnan Hospital

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.